In contrast to MBNL2, MBNL3, a distinct member of the muscleblind family, is downregulated in EpCAMlo colon cancer cells, similar to what reported in prostate cancer by Lu et al., 2015. Here, MBNL2 is linked to malignant colon neoplasm.